Management of Headache Disorders: A Clinical Trial Screening for Prognostic Patient Characteristics
Launched by VRIJE UNIVERSITEIT BRUSSEL · Feb 27, 2006
Trial Information
Current as of August 02, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Dutch speaking
- • Willing to participate
- • At least 18 years old
- • Combination of headache and neck pain
- • Headache since at least two months and at least twice a month
- • A combination of migraine, tension type headache and cervicogenic headache
- Exclusion Criteria:
- • Clusterheadache
- • Trigeminusneuralgia
- • Peripheral neuropathy
- • A history with neck surgery
- • Comorbidity with chronic muskuloskeletal pain like fibromyalgia
- • Radicular pain in the upper extremity
- • Osteoarthritis
- • Down Syndroom
- • Physio/ manual therapy treatment in the last 12 months for this headache complaint.
- • The use of prescribed medication (like NSAIDs and triptans) for this headache complaint during the last two months
- • Pregnancy
- • Red flags as described in the Dutch General Practitioners Headache Guideline
About Vrije Universiteit Brussel
The Vrije Universiteit Brussel (VUB) is a distinguished research university located in Brussels, Belgium, known for its commitment to innovative education and cutting-edge research across various disciplines. As a clinical trial sponsor, VUB actively engages in advancing medical knowledge and improving patient care through rigorous scientific investigations. The university fosters collaborations with healthcare institutions and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. VUB's research initiatives are driven by a multidisciplinary approach, leveraging expertise from fields such as medicine, health sciences, and biomedical engineering to address pressing health challenges and contribute to the development of novel therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aalst, , Belgium
Antwerp, , Belgium
Boom, , Belgium
Brussels, , Belgium
Dilbeek, , Belgium
Hamme, , Belgium
Kampenhout, , Belgium
Laarne, , Belgium
Mechelen, , Belgium
Merchtem, , Belgium
Reet, , Belgium
Reet, , Belgium
Schoten, , Belgium
Zemst, , Belgium
Patients applied
Trial Officials
Willem De Hertogh, MSc
Principal Investigator
Vrije Universiteit Brussel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials